Mild myopathy is associated with COMP but not MATN3 mutations in mouse models of genetic skeletal diseases

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Piróg, Katarzyna A ^a   Katakura, Yoshihisa ^b   Mironov, Aleksandr ^c   Briggs, Michael D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN FIBER; MATRILIN 3; VALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DYSPLASIA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; GENOTYPE; GRIP STRENGTH; LIMB WEAKNESS; MALE; MOUSE; MULTIPLE EPIPHYSEAL DYSPLASIA; MUSCLE WEAKNESS; MUTATIONAL ANALYSIS; MYOPATHY; NONHUMAN; PSEUDOACHONDROPLASIA; SHORT LIMBED DWARFISM; WILD TYPE;

ANIMALS; BONE DISEASES; CARTILAGE OLIGOMERIC MATRIX PROTEIN; DISEASE MODELS, ANIMAL; MATRILIN PROTEINS; MICE; MICE, TRANSGENIC; MUSCLE STRENGTH; MUSCULAR DISEASES; MUTATION;

EID: 84896697981     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082412     Document Type: Article

References (65)

1. Briggs MD, Chapman KL (2002) Pseudoachondroplasia and Multiple Epiphyseal Dysplasia: Mutation Review, Molecular Interactions and Genotype to Phenotype Correlations. Hum Mutat 19: 465-478. doi:10.1002/humu.10066. PubMed: 11968079.
2. Unger S, Hecht JT (2001) Pseudoachondroplasia and multiple epiphyseal dysplasia: New etiologic developments. Am J Med Genet 106: 244-250. doi:10.1002/ajmg.10234.abs. PubMed: 11891674.
3. Briggs MD, Hoffman SM, King LM, Olsen AS, Mohrenweiser H et al. (1995) Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in cartilage oligomeric matrix protein gene. Nat Genet 10: 330-336. doi:10.1038/ng0795-330. PubMed: 7670472.
4. Chapman KL, Mortier GR, Chapman K, Loughlin J, Grant ME et al. (2001) Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia. Nat Genet 28: 493-496. PubMed: 11479597.
5. Czarny-Ratajczak M, Lohiniva J, Rogala P, Kozlowski K, Perälä M et al. (2001) A mutation in COL9A1 Causes Multiple Epiphyseal Dysplasia: Further Evidence for Locus Heterogeneity. Am J Hum Genet 69: 969-980. doi:10.1086/324023. PubMed: 11565064.
6. Briggs MD, Choi HC, Warman ML, Loughlin JA, Wordsworth P, et al. (1994) Genetic Mapping of a Locus for Multiple Epiphyseal Dysplasia (EDM2) to a Region of Chromosome I Containing a Type IX Collagen Gene. Am J Hum Genet 55: 001-005
7. Kennedy J, Jackson GC, Barker FS, Nundlall S, Bella J et al. (2005) Novel and recurrent mutations in the C-terminal domain of COMP cluster in two distinct regions and result in a spectrum of phenotypes within the pseudoachondroplasia - multiple epiphyseal dysplasia disease group. Hum Mutat 6: 593-594.
8. Jackson GC, Marcus-Soekarman D, Stolte-Dijkstra I, Verrips A, Taylor JA et al. (2010) Type IX Collagen Gene Mutations can result in Multiple Epiphyseal Dysplasia that is associated with Osteochondritis Dissecans and a Mild Myopathy. Am J Med Genet A 152A: 863-869. doi:10.1002/ajmg.a.33240. PubMed: 20358595.
9. Jackson GC, Mittaz-Crettol L, Taylor JA, Mortier GR, Spranger J et al. (2012) Pseudoachondroplasia and multiple epiphyseal dysplasia: A 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution. Hum Mutat 33: 144-157. doi:10.1002/humu.21611. PubMed: 21922596.
10. Hecht JT, Deere M, Putnam E, Cole W, Vertel B et al. (1998) Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues. Matrix Biol 17: 269-278. doi:10.1016/S0945-053X(98)90080-4. PubMed: 9749943.
11. Södersten F, Ekman S, Eloranta ML, Heinegård D, Dudhia J et al. (2005) Ultrastructural immunolocalization of cartilage oligomeric matrix protein (COMP) in relation to collagen fibrils in the equine tendon. Matrix Biol 24: 376-385. doi:10.1016/j.matbio.2005.06.003. PubMed: 16005620.
12. Di Cesare PE, Chen FS, Moergelin M, Carlson CS, Leslie MO et al. (2002) Matrix-matrix interactions of cartilage oligomeric matrrix protein and fibronectin. Matrix Biology 21: 461-470. doi:10.1016/S0945-053X(02)00015-X. PubMed: 12225811.
13. Chen FH, Herndon ME, Patel N, Hecht JT, Tuan RS et al. (2007) Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan. J Biol Chem 282: 24591-24598. doi:10.1074/jbc.M611390200. PubMed: 17588949.
14. Mann HH, Ozbek S, Engel J, Paulsson M, Wagener R (2004) Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias. J Biol Chem 279: 25294-25298. doi:10.1074/jbc.M403778200. PubMed: 15075323.
15. Holden P, Meadows RS, Chapman KL, Grant ME, Kadler KE et al. (2001) Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J Biol Chem 276: 6046-6055. doi:10.1074/jbc.M009507200. PubMed: 11087755.
16. Halász K, Kassner A, Mörgelin M, Heinegård D (2007) COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem 282: 31166-31173. doi:10.1074/jbc.M705735200. PubMed: 17716974.
17. Chen FH, Thomas AO, Hecht JT (2005) Cartilage oligomeric matrix protein/thrombonspondin-5 supports chondrocyte attachment through interaction with integrins. J Biol Chem 280: 32655-32661. doi:10.1074/jbc.M504778200. PubMed: 16051604.
18. Rock MJ, Holden P, Horton WA, Cohn DH (2010) Cartilage oligomeric matrix protein promotes cell attachment via two independent mechanisms involving CD47 and alphaVbeta3 integrin. Mol Cell Biochem 338: 215-224. doi:10.1007/s11010-009- 0355-3. PubMed: 20033473.
19. Briggs MD, Mortier GR, Cole WG, King LM, Golik SS et al. (1998) Diverse mutations in the Gene for Cartilage Oligomeric Matrix Protein in the Pseudoachondroplasia-Multiple Epiphyseal Dysplasia Disease. Spectrum - American Journal of Human Genetics 62: 311-319. doi:10.1086/301713.
20. Maddox BK, Keene DR, Sakai LY, Charbonneau NL, Morris NP et al. (1997) The Fate of Cartilage Oligomeric Matrix Protein Is Determined by the Cell Type in the Case of a Novel Mutation in Pseudoachondroplasia. J Biol Chem 272: 30993-30997. doi:10.1074/jbc.272.49.30993. PubMed: 9388247.
21. Hashimoto Y, Tomiyama T, Yamano Y, Mori H (2003) Mutation (D472Y) in the Type 3 Repeat Domain of Cartilage Oligomeric Matrix Protein Affects Its Early Vesicle Trafficking in Endoplasmatic Reticulum and Induces. Apoptosis - American Journal of Pathology 163: 101-109. doi:10.1016/S0002-9440(10)63634-6.
22. Suleman F, Gualeni B, Gregson HJ, Leighton MP, Piróg KA et al. (2012) A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia. Hum Mutat 33: 218-231. PubMed: 22006726.
23. Spitznagel L, Nitsche DP, Paulsson M, Maurer P, Zaucke F (2004) Characterization of a pseudoachondroplasia-associated mutation (His 587-Arg) in the C-terminal, collagen-binding domain of cartilage oligomeric matrix protein (COMP). Journal of Biochemistry 377: 479-487. doi:10.1042/BJ20031179.
24. Piróg-Garcia KA, Meadows RS, Knowles L, Heinegård D, Thornton DJ et al. (2007) Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP. Hum Mol Genet 16: 2072-2088. doi:10.1093/hmg/ddm155. PubMed: 17588960.
25. Piróg KA, Jaka O, Katakura Y, Meadows RS, Kadler KE et al. (2010) A mouse model offers novel insight into the myopathy and tendinopathy that is often associated with pseudoachondroplasia and multiple epiphyseal dysplasia. Hum Mol Genet 19: 52-64. doi:10.1093/hmg/ddp466. PubMed: 19808781.
26. Piróg K, Briggs M (2010) Skeletal dysplasias associated with mild myopathy - a clinical and molecular review. J Biomed Biotechnol epub May 24.
27. Bönnemann CG, Cox GF, Shapiro F, Wu JJ, Feener CA et al. (2000) A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy. Proc of the Natl Acad of Sciences of the USA 97: 1212-1217. doi:10.1073/pnas.97.3.1212. PubMed: 10655510.
28. Belluoccio D, Schenker T, Baici A, Trueb B (1998) Characterization of Human Matrilin-3 (MATN3). Genomics 53: 391-394. doi:10.1006/geno.1998.5519. PubMed: 9799608.
29. Klatt AR, Paulsson M, Wagener R (2002). Expression of matrilins During the Maturation of Mouse Skeletal Tissues 21: 289-296.
30. Wagener R, Ehlen HWA, Ko YP, Kobbe B, Mann HH et al. (2005) The matrilins - adaptor proteins in the extracellular matrix. FEBS Lett 579: 3323-3329. doi:10.1016/j.febslet.2005.03.018. PubMed: 15943978.
31. Fresquet M, Jowitt TA, Ylöstalo J, Coffey P, Meadows RS et al. (2007) Structural and functional characterization of recombinant matrilin-3 A-domain and implications for human genetic bone diseases. J Biol Chem 282: 34634-34643. doi:10.1074/jbc.M705301200. PubMed: 17881354.
32. Jackson GC, Barker FS, Jakkula E, Czarny-Ratajczak M, Mäkitie O et al. (2004) Missense mutations in the b strands of the single A-domain of matrilin-3 result in multiple epiphyseal dysplasia. J Med Genet 41: 52-59. doi:10.1136/jmg.2003.015222. PubMed: 14729835.
33. Cotterill SL, Jackson GC, Leighton MP, Wagener R, Mäkitie O et al. (2005) Multiple epiphyseal dysplasia mutations in MATN3 cause misfolding of the A-domain and prevent secretion of mutant matrilin-3. Hum Mutat 26: 557-567. doi:10.1002/humu.20263. PubMed: 16287128.
34. Leighton MP, Nundlall S, Starborg T, Meadows RS, Suleman F et al. (2007) Decreased chondrocyte proliferation and dysregulated apoptosis in the cartilage growth plate are key features of a murine model of epiphyseal dysplasia caused by a matn3 mutation. Hum Mol Genet 16: 1728-1741. doi:10.1093/hmg/ddm121. PubMed: 17517694.
35. Bodensteiner JB (1994) Congenital myopathies. Muscle and Nerve 17: 131-144. doi:10.1002/mus.880170202. PubMed: 81147813065597.
36. Dubowitz V, Sewry CA, Lane RJM (2007) Muscle biopsy: a practical approach. Elsevier Health Sciences.
37. Schoenau E (2005) From mechanostat theory to development of the "Functional Muscle-Bone-Unit". J Musculoskelet Neuronal Interact 5: 232-238. PubMed: 16172514.
38. Rauch F (2005) Bone growth in length and width: the Yin and Yang of bone stability. J Musculoskelet Neuronal Interact 5: 194-201. PubMed: 16172510.
39. Goh KL, Holmes DF, Lu Y, Purslow PP, Kadler KE et al. (2012) Biomodal collagen fibril diameter distributions direct age-related variations in tendon resilience and resistance to rupture. Journal of Appl Physiol 113: 878-888. doi:10.1152/japplphysiol.00258.2012. PubMed: 22837169.
40. Fukunaga T, Kubo K, Kawakami Y, Fukashiro S, Kanehisa H et al. (2001) In vivo behaviour of human muscle tendon during walking. Proc Biol Sci 268: 229-233. doi:10.1098/rspb.2000.1361. PubMed: 11217891.
41. Ker R (2007) Mechanics of tendon, from an engineering perspective. International Journal of Fatigue 29: 1001-1009. doi:10.1016/j.ijfatigue.2006.09. 020.
42. Wright MJ, Ain MC, Clough MV, Bellus GA, Hurko O et al. (2000) Achondroplasia and nail-patella syndrome: the compound phenotype. J Med Genet 37: E25. doi:10.1136/jmg.37.9.e25. PubMed: 10978372.
43. Staheli L (2007) Fundamentals of Pediatric Orthopedics. Lippincott Williams & Wilkins.
44. Jakkula E, Lohiniva J, Capone A, Bonafe L, Marti M et al. (2003) A recurrent R718W mutation in COMP results in multiple epiphyseal dysplasia with mild myopathy: clinical and pathogenetic overlap with collagen IX mutations. J Med Genet 40: 942-948. doi:10.1136/jmg.40.12.942. PubMed: 14684695.
45. Olsen BR (1997) Collagen IX. International Journal Biochemistry and Cellular Biology 29: 555-558. doi:10.1016/S1357-2725(96)00100-8.
46. Poole CA, Gilbert RT, Herbage D, Hartmann DJ (1997) Immunolocalisation of type IX collagen in normal and spontaneously osteoarthritic canine tibial cartilage and isolated chondrons. Osteoarthritis and Cartilage 5: 191-204. doi:10.1016/S1063-4584(97)80014-3. PubMed: 9219682.
47. Adamczyk C, Milz S, Tischer T, Putz R, Benjamin M (2008) An immunohistochemical study of the extracellular matrix of entheses associated with the human pisiform bone. J Anat 212: 645-653. doi:10.1111/j.1469-7580.2008. 00887.x. PubMed: 18399959.
48. Wu C, Orozco C, Boyer J, Leglise M, Goodale J et al. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10: R130. doi:10.1186/gb-2009-10-11-r130. PubMed: 19919682.
49. Klatt AR, Nitsche DP, Kobbe B, Mörgelin M, Paulsson M et al. (2000) Molecular structure and tissue distribution of matrilin-3, a filament forming extracellular matrix protein expressed during skeletal development. J Biol Chem 275: 3999-4006. doi:10.1074/jbc.275.6.3999. PubMed: 10660556.
50. Segat D, Frie C, Nitsche PD, Klatt AR, Piecha D et al. (2000) Expression of matrilin-1, -2 and -3 in developing mouse limbs and heart. Matrix Biology 19: 649-655. doi:10.1016/S0945-053X(00)00112-8. PubMed: 11102754.
51. Ernst L, Ruchelli E, Huff D (2011) Color Atlas of Fetal and Neonatal Histology. Springer.
52. Kjaer M (2004) Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 84: 649-698. doi:10.1152/physrev.00031.2003. PubMed: 15044685.
53. Schmitz M, Niehoff A, miosge N, Smyth N, Paulsson M, et al. (2008) Transgenic mice expressing D469Δ mutated cartilage oligomeric matrix protein (COMP) show growth plate abnormalities and sternal malformations Matrix Biology 27: 77-85.
54. Benjamin M, Ralphs JR (1996) Tendons in health and disease. Man Ther 1: 186-191. doi:10.1054/math.1996.0267. PubMed: 11440506.
55. Provenzano PP, Hurschler C, Vanderby R (2001) Microstructural morphology in the transition region between scar and intact residual segments of a healing rat medial collateral ligament. Connect Tissue Res 42: 123-133. doi:10.3109/03008200109014254. PubMed: 11718467.
56. Chapman KL, Briggs MD (2003) Review: Clinical variability and genetic heterogeneity in multiple epiphyseal dysplasia. Pediatr Pathol Mol Med 22: 53-75. doi:10.1080/pdp.22.1.53.75. PubMed: 12687890.
57. Tidball JG (1991) Force transmission across muscle cell membranes. J Biomech 24: 43-52. doi:10.1016/0021-9290(91)90376-X. PubMed: 1791181.
58. Garfin SR, Tipton CM, Mubarak SJ, Woo SL, Hargens AR et al. (1981) Role of fascia in maintenance of muscle tension and pressure. J Appl Physiol Respir Environ Exerc Physiol 51: 317-320. PubMed: 7263438.
59. Smith RK, Gerard M, Dowling B, Dart AJ, Birch HL et al. (2002) Correlation of cartilage oligomeric matrix protein (COMP) levels in equine tendon with mechanical properties: a proposed role for COMP in determining function-specific mechanical characteristics of locomotor tendons. Equine Vet J Suppl 34: 241-244. PubMed: 12405694.
60. Schmitz M, Becker A, Schmitz A, Weirich C, Paulsson M et al. (2006) Disruption of extracellular matrix structure may cause pseudoachondroplasia phenotypes in the absence of impaired cartilage oligomeric matrix protein secretion J Biol Chem 281: 32587-32595. doi:10.1074/jbc.M601976200. PubMed: 16928687.
61. Dudhia J, Scott CM, Draper ER, Heinegård D, Pitsillides AA et al. (2007) Aging enhances a mechanically-induced reduction in tendon strength by an active process involving matrix metalloproteinase activity. Aging Cell 6: 547-556. doi:10.1111/j.1474-9726.2007.00307.x. PubMed: 17578513.
62. Rittweger J (2008) Ten years muscle-bone hypothesis: what have we learned so far? - almost a festschrift - . J Musculoskelet Neuronal Interact 8: 174-178. PubMed: 18622086.
63. Fricke O, Schoenau E (2007) The 'Functional Muscle-Bone Unit': probing the relevance of mechanical signals for bone development in children and adolescents. Growth Horm IGF Res 17: 1-9. doi:10.1016/j.ghir.2006.10.004. PubMed: 17194607.
64. Kardon G (2011) Development of the musculoskeletal system: meeting the neighbors. Development 138: 2855-2859. doi:10.1242/dev.067181. PubMed: 21693508.
65. Maas H, Sandercock TG (2010) Force Transmission between Synergistic Skeletal Muscles through Connective Tissue Linkages. J Biomed Biotechnol Epub 2010 April 12. PubMed: 20396618.